Advertisement
Table 1 Demographic and baseline characteristics of 138 patients with metastatic breast cancer
| Characteristic | HT group (n = 59) | MCT group (n = 79) | P value |
|---|---|---|---|
| Age (years)a | 0.009 (t test) | ||
| Median | 49 | 50 | |
| Range | 37–76 | 34–66 | |
| KPS score | 0.349 | ||
| 90–100 | 46 (78.0) | 56 (70.9) | |
| 70–80 | 13 (22.0) | 23 (29.1) | |
| Menopausal status | 0.520 | ||
| Premenopausal | 20 (33.9) | 31 (39.2) | |
| Postmenopausal | 39 (66.1) | 48 (60.8) | |
| HR status | |||
| ER-positive | 55 (93.2) | 73 (92.4) | 0.855 |
| PgR-positive | 51 (86.4) | 65 (82.2) | 0.509 |
| Adjuvant HT | 0.246 | ||
| Yes | 50 (84.7) | 72 (91.1) | |
| No | 9 (15.3) | 7 (8.9) | |
| DFS (years) | 0.446 | ||
| <2 | 16 (27.1) | 17 (21.5) | |
| ≥2 | 43 (72.9) | 62 (78.5) | |
| Mediana (months) | 44 | 42 | 0.178 (t test) |
| No. of metastases | 0.006 | ||
| <2 | 30 (50.9) | 22 (27.9) | |
| ≥2 | 29 (49.1) | 57 (72.1) | |
| Metastatic sites | 0.168 | ||
| Viscera | 32 (54.2) | 52 (65.8) | |
| Non-viscera | 27 (45.8) | 27 (34.2) | |
| Prior adjuvant CT | |||
| Anthracycline | 54 (91.5) | 70 (88.6) | 0.749 |
| Taxanes | 32 (54.2) | 53 (67.1) | 0.170 |
| Response to FCCT | 0.009 | ||
| CR + PR | 28 (47.4) | 55 (69.6) | |
| SD | 31 (52.3) | 24 (30.4) |
